flow trial semaglutide Effects of With or Without Concomitant Mineralocorticoid Receptor Antagonist Use in Participants With Type 2 Diabetes and Chronic Kidney Disease: A Prespecified Secondary Analysis flow trial semaglutide kidney outcomes

PlexusDx medications are compounded by licensed 503A pharmacies using the same active pharmaceutical ingredients found in FDA-approved GLP-1 drugs, but at lower cost

Conflict of interest LB is employed by company Pregmama, LLC, Gaithersburg, MD, United States

If you experience leg cramps while taking semaglutide, several evidence-based strategies may help manage and prevent these symptoms while continuing treatment

Intestinal obstruction may be a potentially life-threatening problem due to the serious complications that can occur, like bowel perforation, gangrene, and infection

PMID: Summary Keywords GIP/GLP-1 receptor agonist, glucagon-like peptide 1 receptor agonist, glucocorticosteroids, semaglutide, steroid-induced diabetes, steroid-induced hyperglycaemia Citation Jdrasek A, Lisowska K and Czupryniak L (2026) Evaluation of GLP-1 receptor agonist therapy in the management of steroid-induced diabetes: a narrative review